Page last updated: 2024-09-04

2-methyl-1,1-diphenyl-3-(1-piperidinyl)-1-propanol and Psychoses, Drug

2-methyl-1,1-diphenyl-3-(1-piperidinyl)-1-propanol has been researched along with Psychoses, Drug in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, RF; Gerona, RR; Lo, J; Thornton, SL; Wu, AH1

Other Studies

1 other study(ies) available for 2-methyl-1,1-diphenyl-3-(1-piperidinyl)-1-propanol and Psychoses, Drug

ArticleYear
Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.
    Clinical toxicology (Philadelphia, Pa.), 2012, Volume: 50, Issue:10

    Topics: Adolescent; Cannabinoids; Cyclohexanols; Designer Drugs; Drug Interactions; Drug Therapy, Combination; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phenols; Piperidines; Psychoses, Substance-Induced; Substance Abuse Detection

2012